Group 1 - The core viewpoint of the news highlights the increasing trend of fund managers investing in newly launched floating rate funds, indicating a shift in investment strategies within the mutual fund industry [1][1]. - Xingsheng Global Fund announced a plan to invest 20 million yuan in its newly launched Xingsheng Global Hexi Mixed Securities Investment Fund, which is one of the first floating rate funds [1]. - China Europe Fund also reported a 10 million yuan investment in its floating rate fund, committing to hold the investment for no less than three years [1]. Group 2 - Hong Kong-themed ETFs have seen significant inflows this year, with a total increase of 85.674 billion yuan, representing a growth rate of 27.97%, bringing the total size close to 400 billion yuan at 391.962 billion yuan as of May 30 [2]. - The number of Hong Kong-themed ETFs with over 10 billion yuan in assets has increased from 8 at the end of last year to 11 by the end of May [3]. - The number of fund managers managing Hong Kong-themed ETFs with over 10 billion yuan has risen from 7 to 10, indicating a trend towards concentration in the market [3]. Group 3 - Some off-market QDII funds have relaxed their purchase limits, with Hai Futong's USD bond fund increasing its limit from 50,000 yuan to 30 million yuan [4]. - A total of 6 new QDII funds have been approved this year, primarily focusing on the Hong Kong stock market, including several ETFs targeting the Hang Seng Technology Index [4]. Group 4 - The issuance scale of ETFs has experienced a decline for four consecutive months, with May seeing a significant drop to 11.068 billion units, down from 34.014 billion units in January [5]. - In May, public fund managers focused on launching products related to digital economy, sci-tech innovation board, and free cash flow themes [6]. Group 5 - In May, there was a notable shift in ETF fund flows, with significant inflows into technology-related ETFs, particularly in sectors like semiconductors and defense, attracting over 20 billion yuan in net inflows [7]. - The top three ETFs attracting the most net inflows in May were Huaxia Sci-Tech 50 ETF, Guolian An Semiconductor ETF, and Jiashi Sci-Tech Chip ETF, with inflows of 4.931 billion yuan, 2.364 billion yuan, and 1.874 billion yuan respectively [8]. Group 6 - Qiu Yang has left his position as the manager of the Qianhai Kaiyuan Artificial Intelligence Mixed Fund due to internal adjustments, with the fund now managed by Wei Chun [9]. - As of the end of the first quarter, the A-class share of the fund managed by Qiu Yang had a scale of 688 million yuan, achieving a return of 14.19% during his tenure [9].

Fund News Overview - Xingsheng Global Fund plans to use its own funds of 20 million yuan to subscribe to its mixed securities investment fund, Xingsheng Global Hexi [1] - Hong Kong-themed ETFs have seen significant inflows this year, with a total growth of 85.674 billion yuan, representing a 27.97% increase, bringing the total size close to 400 billion yuan at 391.962 billion yuan as of May 30 [2] - Some off-market QDII funds have relaxed purchase limits, likely due to a decrease in interest in on-market cross-border ETFs [3] Notable Fund Manager Updates - Qu Yang has left his position as the manager of the Qianhai Kaiyuan Artificial Intelligence Mixed Fund due to internal adjustments, with Wei Chun continuing to manage the fund [4] ETF Market Commentary - The market experienced a rebound, with the Shanghai Composite Index rising by 0.42%, the Shenzhen Component Index by 0.87%, and the ChiNext Index by 1.11%. The total trading volume reached 1.15 trillion yuan, an increase of 11.6 billion yuan from the previous trading day [5] - Hong Kong innovative drug-related ETFs performed strongly, with the highest increase of 4.29% [5] ETF Performance - The Hong Kong Innovation Drug ETF saw a price increase of 4.29%, while the overall performance of various ETFs showed a mixed trend, with the Greater Bay Area ETF leading the decline at -1.40% [6][7] ETF Thematic Opportunities - Domestic favorable policies are encouraging high-quality innovation, which may continue to drive rapid growth in corporate performance. The valuation levels of domestic innovative drugs are low, and some products have the potential to be globally competitive. Analysts remain optimistic about innovative drugs leveraging international markets to enhance valuations [8] Upcoming Fund Launches - The upcoming fund, Yongying Shanghai Stock Exchange Science and Technology Innovation Board 50 Index, is an index-type stock fund managed by Chu Kefa, with a performance benchmark linked to the index's returns [9]